Fengfeng Mao
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 10%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Mycobacterium research and diagnosis
Papers in
- Epidemiology 12
- Hepatitis B Virus Studies 5
- Mycobacterium research and diagnosis 2
-
- Tuberculosis Research and Epidemiology 7
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Wenhui Li (8 shared papers)Changhong Shi (8 shared papers)Jianhua Sui (6 shared papers)Wenhui He (5 shared papers)Bing Bai (7 shared papers)Yonghe Qi (3 shared papers)Yinyan Sun (3 shared papers)Zhikai Xu (5 shared papers)
- Journals
- Journal of Medical Virology (2 papers)Journal of Medicinal Chemistry (1 paper)British Journal of Urology (1 paper)Pathogens and Disease (1 paper)DNA and Cell Biology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Fengfeng Mao
21 papers receiving 499 citations
Peers
Comparison fields: 5 of 63
- Hepatology 145
- Epidemiology 320
- Infectious Diseases 166
- Immunology 86
- Urology 16
Countries citing papers authored by Fengfeng Mao
This map shows the geographic impact of Fengfeng Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Mao more than expected).
Fields of papers citing papers by Fengfeng Mao
This network shows the impact of papers produced by Fengfeng Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Mao. The network helps show where Fengfeng Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengfeng Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 93 | |
| 2 | 2017 | 83 | |
| 3 | 2011 | 44 | |
| 4 | 2014 | 43 | |
| 5 | 2010 | 41 | |
| 6 | 2016 | 39 | |
| 7 | 2019 | 27 | |
| 8 | 2012 | 20 | |
| 9 | 2012 | 19 | |
| 10 | 2011 | 17 | |
| 11 | 2010 | 16 | |
| 12 | 2020 | 15 | |
| 13 | 2015 | 12 | |
| 14 | 2023 | 7 | |
| 15 | 2021 | 7 | |
| 16 | 2014 | 7 | |
| 17 | 2015 | 6 | |
| 18 | 2011 | 4 | |
| 19 | 2014 | 2 | |
| 20 | [Effects of Mycobacterium tuberculosis Hsp16.3 protein on the autophagy function of mice macrophages]. | 2011 | 2 |
About Fengfeng Mao
Fengfeng Mao is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Immunology and Hepatology, having authored 21 papers that have together received 505 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (7 papers), Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Mycobacterium research and diagnosis (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), BRCA gene mutations in cancer (1 paper) and Vibrio bacteria research studies (1 paper). The work is most often cited by research in Hepatology (145 citations), Epidemiology (320 citations), Infectious Diseases (166 citations), Immunology (86 citations) and Urology (16 citations). Fengfeng Mao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wenhui Li, Changhong Shi, Jianhua Sui, Wenhui He, Bing Bai, Yonghe Qi, Yinyan Sun, Zhikai Xu, Huan Yan and Caiqin Zhang. Their work appears in journals such as Journal of Medical Virology, Journal of Medicinal Chemistry, British Journal of Urology, Pathogens and Disease and DNA and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.